DOD's Drug Price Controls Unfair, DC Circ. Hears
A government contractor trade group on Wednesday urged the D.C. Circuit to reverse a ruling upholding the U.S. Department of Defense's authority to impose involuntary price controls on drugmakers for drugs...To view the full article, register now.
Already a subscriber? Click here to view full article